12-Month Lobbying Summary - In-house Corporation

Return to 12-Month Lobbying Activity Search Results

Moderna Biopharma Canada Corporation / Stefan Raos, General Manager, Canada

Registration Summary

Active - Last Updated: 2024-07-08

Who is lobbying?

Moderna Biopharma Canada Corporation (Address & business activities)

Stefan Raos, General Manager, Canada

Responsible officer in previous versions
- Patricia Gauthier, General Manager, Canada

Received government funding or funding expected in current financial year

Yes

Business Relationships

Moderna Biopharma Canada Corporation is a subsidiary of the following parent companies

Moderna TX, Inc. (Address information)

Beneficiaries of the Lobbying Activity

Moderna Biopharma Canada Corporation has the following subsidiaries that could have a direct interest in the outcome of the undertaking

Moderna Manufacturing Canada Corp. (Address information)

What is being lobbied?

Subject Matter Details

Details Regarding the Identified Subject Matter
Subject matters	Details	Categories
Research and Development, Science and Technology	Government policies regarding innovation, research and development, and messenger ribonucleic acid (mRNA) biotechnology	Policies or Program
Government Procurement, Health	Health Canada and Public Services and Procurement Canada policies regarding the development, procurement, and distribution of Moderna’s COVID-19 vaccine to various segments of the population, including future distribution models	Policies or Program
Economic Development, Health	The government’s Pandemic Preparedness Strategy as it relates to the corporation’s future operations in Canada	Policies or Program

Subject matter details in previous versions

Details Regarding the Identified Subject Matter
Subject matters	Details	Categories
Subject matters were not required to be associated with subject matter details when this content was submitted	Government policies regarding innovation, research and development, and messenger ribonucleic acid (mRNA) biotechnology	Policies or Program
Subject matters were not required to be associated with subject matter details when this content was submitted	Health Canada and Public Services and Procurement Canada policies regarding the development, procurement, and distribution of Moderna’s COVID-19 vaccine to various segments of the population, including future distribution models	Policies or Program
Subject matters were not required to be associated with subject matter details when this content was submitted	The government’s Pandemic Preparedness Strategy as it relates to the corporation’s future operations in Canada	Policies or Program

Subject matters in previous versions

Economic Development
Government Procurement
Health
Research and Development
Science and Technology

Subject matters added through a communication report:

Government Procurement
Health
Health
Research and Development
Science and Technology
Economic Development
Research and Development
Science and Technology
Economic Development
Science and Technology
Economic Development
Health
Health
Research and Development
Government Procurement
Health
Health
Health
Government Procurement
Health
Research and Development
Science and Technology
Government Procurement
Health

Who is being lobbied?

Government Institutions

Federal Economic Development Agency for Southern Ontario (FedDev)
Global Affairs Canada (GAC)
Health Canada (HC)
House of Commons
Innovation, Science and Economic Development Canada (ISED)
Prairies Economic Development Canada (PrairiesCan)
Privy Council Office (PCO)
Public Health Agency of Canada (PHAC)
Public Services and Procurement Canada (PSPC)
Treasury Board Of Canada Secretariat (TBS)

Communication techniques

Communication techniques that have been used or are expected to be used in the course of the undertaking:

Oral communication
Written communication

Who are the lobbyists?

Senior Officers whose lobbying activities represent less than 20% of their Duties

Laura Fitzgerald, Associate Director, Government Affairs and Policy | No public offices held
Shehzad Iqbal, Sr. Medical Director | No public offices held
Kavisha Jayasundara, Director, Market Access and Innovative Partnerships | No public offices held
Leslie Madden, Sr. Director, Regulatory Science and Quality Assurance | No public offices held
Roger Ngassam, Site Head, Canada | No public offices held
Rahbar Rahimpour, Director, R&D Strategic Alliances | No public offices held
Stefan Raos, General Manager | No public offices held
Lisa Wise-Milestone, Strategic Lead for Pandemic Preparedness Initiative | No public offices held

Senior Officers and Employees whose lobbying activities represent 20% or more of their Duties

No lobbyists added

Lobbyists in previous versions
Senior Officers whose lobbying activities represent less than 20% of their Duties
- Patricia Gauthier, General Manager, Canada | No public offices held
- Stefan Raos, Director, Market Access and Innovative Partnerships | No public offices held

Registration number: 956349-370107
View all registrations versions

Monthly Communication Reports

What oral and arranged communications have taken place?

What oral and arranged communications have taken place?
Date	DPOH, Position Title \| Government Institution	Subject Matters
2024-05-13	Mollie Royds, Associate Assistant Deputy Minister Public Services and Procurement Canada (PSPC)	Government Procurement, Health
2024-04-03	Ritu Banerjee, Assistant Deputy Minister \| Director General's Office, Innovation, Science and Economic Development Canada (ISED) Christopher Johnstone, Assistant Deputy Minister Health Canada (HC)	Health, Research and Development, Science and Technology, Economic Development
2024-04-02	Ritu Banerjee, Assistant Deputy Minister \| Director General's Office, Innovation, Science and Economic Development Canada (ISED)	Research and Development, Science and Technology, Economic Development
2024-01-17	Michele Evans, Assistant Deputy Minister, Alberta Prairies Economic Development Canada (PrairiesCan)	Science and Technology, Economic Development
2023-12-12	Mark Holland, Minister of Health Health Canada (HC)	Health
2023-12-08	Joel Dennis, Director General Public Health Agency of Canada (PHAC)	Health, Research and Development
2023-11-08	Andrea Andrachuk, Director General Public Services and Procurement Canada (PSPC) Joel Dennis, Director General Public Health Agency of Canada (PHAC)	Government Procurement, Health
2023-10-27	Mark Holland, Minister of Health Health Canada (HC) Annie Koutrakis, Member of Parliament House of Commons	Health
2023-10-06	Joel Denis, Director General Public Health Agency of Canada (PHAC)	Health
2023-10-04	Andrea Andrachuk, Director General Public Services and Procurement Canada (PSPC) Ritu Banerjee, Assistant Deputy Minister \| Director General's Office, Innovation, Science and Economic Development Canada (ISED) Joel Dennis, Director General Public Health Agency of Canada (PHAC) Christopher Johnstone, Assistant Deputy Minister Health Canada (HC) Darryl Patterson, Director General Innovation, Science and Economic Development Canada (ISED) Mollie Royds, Associate Assistant Deputy Minister Public Services and Procurement Canada (PSPC) Donald Sheppard, Vice President Public Health Agency of Canada (PHAC) Melissa Sutherland, Director General Public Health Agency of Canada (PHAC)	Government Procurement, Health, Research and Development, Science and Technology
2023-10-03	Andrea Andrachuk, Director General Public Services and Procurement Canada (PSPC) Joel Dennis, Director General Public Health Agency of Canada (PHAC) Mollie Royds, Associate Assistant Deputy Minister Public Services and Procurement Canada (PSPC) Donald Sheppard, Vice President Public Health Agency of Canada (PHAC)	Government Procurement, Health

View all monthly communication reports

Return to 12-Month Lobbying Activity Search Results

Moderna Biopharma Canada Corporation - Address & business activities

Address:

155 Wellington St W
Suite 3130
Toronto, ON M5V 3H1
Canada

Telephone number: 647-503-0703

Contact information in previous versions
- 666 Burrard Street
  Suite 1700, Park Place
  Vancouver, BC V6C 2X8
  Canada
  
  Telephone number: 647-503-0703
- 666 Burrard Street
  Suite 1700, Park Place
  Vancouver, BC V6C 2X8
  Canada
  
  Telephone number: 416-859-0079

Description of activities:
Moderna is a biotech company focusing on vaccine technologies. We are pioneering a new class of medicines made of messenger RNA, or mRNA. The potential implications of using mRNA as a drug are significant and far-reaching and could meaningfully improve how medicines are discovered, developed and manufactured.

Descriptions of the corporation's activity in previous versions:
- Moderna is an American biotech company focusing on vaccine technologies. We are pioneering a new class of medicines made of messenger RNA, or mRNA. The potential implications of using mRNA as a drug are significant and far-reaching and could meaningfully improve how medicines are discovered, developed and manufactured.

End date of the last completed financial year: 2023-12-31

List of Government Funding
Government Institution	Funding Received in Last Financial Year	Funding Expected in Current Financial Year
Investissement Quebec	$733,257.00	Yes
Ministry of Economic Development, Job Creation and Trade	$2,400,000.00	Yes

Government funding in previous versions

List of Government Funding
End date of the last completed financial year	Government Institution	Funding Received in Last Financial Year	Funding Expected in Current Financial Year
2022-12-31	Investissement Quebec	No	Yes
2022-12-31	Ministry of Economic Development, Job Creation and Trade	No	Yes

Search and menus

Language selection

12-Month Lobbying Summary - In-house Corporation

Moderna Biopharma Canada Corporation / Stefan Raos, General Manager, Canada

Who is lobbying?

Moderna Biopharma Canada Corporation (Address & business activities)

Received government funding or funding expected in current financial year

Business Relationships

Moderna Biopharma Canada Corporation is a subsidiary of the following parent companies

Beneficiaries of the Lobbying Activity

Moderna Biopharma Canada Corporation has the following subsidiaries that could have a direct interest in the outcome of the undertaking

What is being lobbied?

Subject Matter Details

Subject matters in previous versions

Subject matters added through a communication report:

Who is being lobbied?

Government Institutions

Communication techniques

Who are the lobbyists?

Senior Officers whose lobbying activities represent less than 20% of their Duties

Senior Officers and Employees whose lobbying activities represent 20% or more of their Duties

Senior Officers whose lobbying activities represent less than 20% of their Duties

What oral and arranged communications have taken place?

12-Month Lobbying Summary - In-house Corporation

Moderna Biopharma Canada Corporation / Stefan Raos, General Manager, Canada

Moderna Biopharma Canada Corporation (Address & business activities)

Received government funding or funding expected in current financial year

Business Relationships

Moderna Biopharma Canada Corporation is a subsidiary of the following parent companies

Beneficiaries of the Lobbying Activity

Moderna Biopharma Canada Corporation has the following subsidiaries that could have a direct interest in the outcome of the undertaking

Subject Matter Details

Subject matters in previous versions

Subject matters added through a communication report:

Government Institutions

Communication techniques

Senior Officers whose lobbying activities represent less than 20% of their Duties

Senior Officers and Employees whose lobbying activities represent 20% or more of their Duties

Senior Officers whose lobbying activities represent less than 20% of their Duties

Moderna Biopharma Canada Corporation - Address & business activities

Moderna Manufacturing Canada Corp.

Moderna TX, Inc.